Skip to main content

Table 4 The characteristics of the 15 patients with positive results for infectious causes

From: Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis

Patient, No.

Age

Sex

Time from AE-IPF to death (days)

Prior treatment for IPF

Treatment for AE-IPF

Mechanical ventilation

Bacteria

Virus

Fungus

1

74

M

1

None

None

No

-

-

Aspergillus species

2

68

M

8

CS

High dose corticosteroids, CPA

Yes

-

CMV

-

3

66

M

10

None

High dose corticosteroids

Yes

-

-

Aspergillus species

4

67

M

12

None

High dose corticosteroids

Yes

GPC

-

-

5

76

F

13

CS

High dose corticosteroids, CPA

Yes

-

-

Candia albicans

6

78

M

15

None

High dose corticosteroids

No

GNR

CMV

-

7

68

M

19

None

High dose corticosteroids, CPA

Yes

GPC

-

-

8

83

M

19

CS, CsA

High dose corticosteroids, CsA

No

-

-

Aspergillus species

9

71

M

20

CS

High dose corticosteroids

Yes

-

-

Aspergillus species

10

68

M

22

None

High dose corticosteroids

Yes

-

CMV

-

11

81

M

35

CS

High dose corticosteroids, CPA

No

-

-

Aspergillus species

12

68

F

38

None

High dose corticosteroids, CPA

Yes

-

CMV

-

13

59

M

41

CS, CsA

High dose corticosteroids

No

GPC, GNR

CMV

-

14

76

M

58

None

High dose corticosteroids, CPA

Yes

-

CMV

-

15

80

M

122

CS

High dose corticosteroids

No

GNR

-

Aspergillus species

  1. Abbreviations: AE-IPF Acute exacerbation of idiopathic pulmonary fibrosis, CS Corticosteroid, CPA Cyclophosphamide, CsA Cyclosporine, GPC Gram-positive cocci, GNR Gram-negative rods, CMV Cytomegalovirus.